Ladies who take birth control medicine that contain drospirenone, a artificial progesterone, have a significantly higher risk of developing life-threatening blood clots and sudden caridac arrest. In clinical studies drospirenone has been found to extend the chance of hyperkalemia, an abnormally high concentration of potassium within the bloodstream. Hyperkalemia is characterised by irregular heartbeat, nausea, and a slow, weak pulse. In otherwise healthy ladies with no history of heart disease, untreated hyperkalemia will cause sudden cardiac arrest.
Hyperkalemia conjointly increases a lady's risk of developing a blood clot, or thrombus. Clots are most likely to form in giant veins in the legs, a condition called Deep Vein Thrombosis, or DVT. A thrombus, or clot, is dangerous as a result of of its potential to block blood flow within the blood vessel where it forms, starving the tissues of oxygen. The worse outcome is for the clot to break loose and travel through the circulatory system to the lungs or the center, where it can cause life-threatening problems.
A clot that lodges in a main artery of the lungs is called a pulmonary embolism. Signs of a pulmonary embolism include shortness of breath, fast respiration, chest pain, and cyanosis (bluish discoloration of the fingers and lips that indicates insufficient oxygen in the blood). A pulmonary embolism can tough to diagnose, and if it is not treated, it will be fatal. About fifteen% of all sudden deaths are caused by pulmonary embolisms. A clot can conjointly lodge in a major artery and block blood flow to the brain. This could end in a stroke.
Since a birth control pill containing drospirenone was brought to market in 2003, physicians and researchers have documented the damaging aspect effects of this drug. The same year it had been introduced, Dutch physicians reported on five cases of ladies developing DVT or pulmonary thrombosis when they started using it. One in all them, 17-year old woman in good health who had taken the pill for 6 months, collapsed suddenly and died shortly afterward. Autopsy revealed a large pulmonary embolism.
A study printed in 2009 within the widely respected British Journal of Medicine followed many thousand Danish ladies age 15-forty nine who used oral contraceptives, and who had no history of heart or circulatory problems. They were divided into 2 groups, those who used contraceptives that contained drospirenone, and those whose contraceptives failed to have drospirenone. Health outcomes for the 2 groups were compared. Researchers found significantly a lot of occurrences of DVT and pulmonary embolism in the cluster using contraceptives that contained drospirenone.
Despite the accumulating proof that use of these medication caused serious health problems, and had been linked to additional than 50 deaths, the manufacturer continued to market them aggressively, and to reap enormous profits. In 2008 the manufacturer created additional than $1.eight billion from sales of its birth management pill with drosperinone.
In October 2009 the corporate acknowledged that it had been facing more than a hundred twenty five lawsuits by girls who had been created seriously ill from its drug. Lawyers acquainted with the cases anticipate that as the suits become a lot of widely known, several a lot of women will return forward with their experiences of health problems. If you have got used an oral contraceptive containing drospirenone and have experienced DVT or a pulmonary embolism, you will want to consult an experienced pharmaceutical lawyer to determine whether you have got a claim.
Author Resource:
Howard has been writing articles online for nearly 2 years now. Not only does this author specialize in Contraceptives Birth Control, you can also check out his latest website about:
![[Valid RSS feed]](http://www.look4articles.com/images/icon_Rss.png "XML Feed For RSS"){kind=icon}
Category Rss Feed
Print This Article
Add To Favorites
![[Valid RSS feed]](http://www.look4articles.com/images/rss.jpg "XML Feed For RSS")